BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24722856)

  • 1. Screening and regulatory network analysis of survival-related genes of patients with colorectal cancer.
    Qi L; Ding Y
    Sci China Life Sci; 2014 May; 57(5):526-31. PubMed ID: 24722856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the CREB5 regulatory network in colorectal cancer metastasis.
    Qi L; Ding Y
    Yi Chuan; 2014 Jul; 36(7):679-84. PubMed ID: 25076032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of metastasis associated signal regulatory network in colorectal cancer.
    Qi L; Ding Y
    Biochem Biophys Res Commun; 2018 Jun; 501(1):113-118. PubMed ID: 29704502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key pathways and genes in mutant KRAS colorectal cancer by integrated bioinformatics analysis.
    Zhang H; Zhang X; Chen X; Zhang W; Xian J; Zhou X; Yang J; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):615-617. PubMed ID: 29688256
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and pathway enrichment analysis for integrated regulatory network of high- and low-metastatic lung cancer.
    Chen QY; Jiao DM; Wu YQ; Wang L; Hu HZ; Song J; Yan J; Wu LJ
    Mol Biosyst; 2013 Dec; 9(12):3080-90. PubMed ID: 24077187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
    Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
    Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome network analysis reveals potential candidate genes for squamous lung cancer.
    Bai J; Hu S
    Int J Mol Med; 2012 Jan; 29(1):95-101. PubMed ID: 21922129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis.
    Hong Y; Ho KS; Eu KW; Cheah PY
    Clin Cancer Res; 2007 Feb; 13(4):1107-14. PubMed ID: 17317818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integer programming-based method for completing signaling pathways and its application to analysis of colorectal cancer.
    Tamura T; Yamanishi Y; Tanabe M; Goto S; Kanehisa M; Horimoto K; Akutsu T
    Genome Inform; 2010; 24():193-203. PubMed ID: 22081600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages].
    Li X; Shen S; Wu M; Li X; Xiong W; Lu J; Zhou M; Ma J; Xiang J; Zeng Z; Xiang B; Zhou Y; Xiao L; Zhou H; Fan S; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):585-91. PubMed ID: 21873780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
    Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
    Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.